Sanjay Aggarwal

2.6k total citations · 1 hit paper
49 papers, 1.6k citations indexed

About

Sanjay Aggarwal is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Sanjay Aggarwal has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 15 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Sanjay Aggarwal's work include Multiple Myeloma Research and Treatments (17 papers), Protein Degradation and Inhibitors (9 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Sanjay Aggarwal is often cited by papers focused on Multiple Myeloma Research and Treatments (17 papers), Protein Degradation and Inhibitors (9 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Sanjay Aggarwal collaborates with scholars based in United States, India and Spain. Sanjay Aggarwal's co-authors include Roderick MacKinnon, Mary K. Nixon, Paula Cloutier, Carlos Bachier, René Gerrets, Preet Kaur, Асок Де, Olivier Schueller, Philippe Moreau and Roman Hájek and has published in prestigious journals such as Neuron, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sanjay Aggarwal

47 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Contribution of the S4 Segment to Gating Charge in the Shaker K+ Channel

1996 585 citations Sanjay Aggarwal, Roderick MacKinnon Neuron profile →

Peers

Countries citing papers authored by Sanjay Aggarwal

Since Specialization

Citations

This map shows the geographic impact of Sanjay Aggarwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjay Aggarwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjay Aggarwal more than expected).

Fields of papers citing papers by Sanjay Aggarwal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanjay Aggarwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjay Aggarwal. The network helps show where Sanjay Aggarwal may publish in the future.

Co-authorship network of co-authors of Sanjay Aggarwal

This figure shows the co-authorship network connecting the top 25 collaborators of Sanjay Aggarwal. A scholar is included among the top collaborators of Sanjay Aggarwal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanjay Aggarwal. Sanjay Aggarwal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) after 2 or More Prior Lines of Therapy: The Rockstar Study (KD025-213) 2021 ·Transplantation and Cellular Therapy ·Corey Cutler, Stephanie J. Lee, Sally Arai, Marcello Rotta, Behyar Zoghi, Aravind Ramakrishnan, Aleksandr Lazaryan, David Eiznhamer, Olivier Schueller, Zhongming Yang, (unknown), Sanjay Aggarwal, Bruce R. Blazar, Steven Z. Pavletic, Madan Jagasia	3
2	The Effect of Post-Operative Handgrip Exercise on the Maturation of Arteriovenous Fistula: a Randomized Controlled Trial 2020 ·Indian Journal of Surgery ·(unknown), (unknown), Devender Singh, (unknown), (unknown), Vishnubhatla Sreenivas, Sanjay Aggarwal	3
3	1339P Clinicopathological characteristics and treatment patterns observed in real-world care in patients with advanced non-small cell lung cancer (NSCLC) and KRAS G12C mutations in the Flatiron Health (FH)-Foundation Medicine (FMI) Clinico-Genomic Database (CGDB) 2020 ·Annals of Oncology ·Sanjay Aggarwal, (unknown), (unknown), Huakang Tu, Gillis Carrigan, (unknown), Gataree Ngarmchamnanrith, Victoria Chia	6
4	Epidemiology and Treatment of Chronic Graft-versus-Host Disease Post-Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis 2020 ·Transplantation and Cellular Therapy ·Carlos Bachier, Sanjay Aggarwal, (unknown), (unknown), Kevin Francis, (unknown), Marcello Rotta	44
5	KD025 for Patients with Chronic Graft-Versus-Host Disease (cGVHD) - Long-Term Follow-up of a Phase 2a Study (KD025-208) 2019 ·Blood ·Madan Jagasia, Amandeep Salhotra, Carlos Bachier, Behyar Zoghi, Aleksandr Lazaryan, Daniel J. Weisdorf, James Essell, (unknown), Olivier Schueller, (unknown), Zhongming Yang, David Eiznhamer, Sanjay Aggarwal, Bruce R. Blazar, Stephanie J. Lee	5
6	KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) — Pharmacodynamics and Updated Results 2018 ·Blood ·Madan Jagasia, Amandeep Salhotra, Carlos Bachier, James Essell, Daniel J. Weisdorf, Behyar Zoghi, (unknown), Olivier Schueller, Alexandra Zanin‐Zhorov, Jonathan M. Weiss, David Eiznhamer, Sanjay Aggarwal, Bruce R. Blazar, Stephanie J. Lee	6
7	Carfilzomib–lenalidomide–dexamethasone vs lenalidomide–dexamethasone in relapsed multiple myeloma by previous treatment 2017 ·Blood Cancer Journal ·Meletios Α. Dimopoulos, A. Keith Stewart, Tamás Masszi, Ivan Špıčka, Albert Oriol, Roman Hájek, Laura Rosiñol, David S. Siegel, Georgi Mihaylov, (unknown), Péter Rajnics, Aleksandr Suvorov, Rubén Niesvizky, Andrzej Jakubowiak, Jesús F. San Miguel, Heinz Ludwig, Sunhee Ro, Sanjay Aggarwal, Philippe Moreau, Antonio Palumbo	44
8	Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes 2017 ·Leukemia ·Parameswaran Hari, MV Mateos, Rafat Abonour, Stefan Knop, Jack W. Singer, Heinz Ludwig, Kevin Song, Roman Hájek, Philippe Moreau, David S. Siegel, Shibao Feng, Mihaela Obreja, Sanjay Aggarwal, Karim Iskander, Hartmut Goldschmidt	16
9	Phase 3 Study (CLARION) of Carfilzomib, Melphalan, Prednisone (KMP) v Bortezomib, Melphalan, Prednisone (VMP) in Newly Diagnosed Multiple Myeloma (NDMM) 2017 ·Clinical Lymphoma Myeloma & Leukemia ·Thierry Façon, Jae Hoon Lee, Philippe Moreau, Rubén Niesvizky, Meletios Α. Dimopoulos, Roman Hájek, (unknown), Sanjay Aggarwal, Zandra Klippel, Jesús F. San Miguel	30
10	CHAMPION-1: a phase 1/2 study of once-weekly carfilzomib and dexamethasone for relapsed or refractory multiple myeloma 2016 ·Blood ·James R. Berenson, Alan Cartmell, Alberto Bessudo, Roger M. Lyons, Wael A. Harb, Dimitrios Tzachanis, Richy Agajanian, Ralph V. Boccia, Morton Coleman, Robert A. Moss, Robert M. Rifkin, Priti Patel, (unknown), Ying Ou, Janet L. Anderl, Sanjay Aggarwal, Jesús G. Berdeja	82
11	Once-Weekly Carfilzomib with Dexamethasone Demonstrated Promising Safety and Efficacy in Patients with Relapsed or Refractory Multiple Myeloma Regardless of Age and Prior Bortezomib Exposure 2016 ·Blood ·Jesús G. Berdeja, Robert M. Rifkin, Roger M. Lyons, Hui Yang, (unknown), Sanjay Aggarwal, Karim Iskander, James R. Berenson	1
12	Design of compact rectangular patch antenna using square grid and I shaped metamaterial 2015 ·Preet Kaur, Sanjay Aggarwal, Асок Де	4
13	Exploring a Dutch paradox: an ethnographic investigation of gay men's mental health 2013 ·Culture Health & Sexuality ·Sanjay Aggarwal, René Gerrets	25
14	Venous thromboembolism prophylaxis in medical ICU patients in Asia (VOICE Asia): A multicenter, observational, cross-sectional study 2012 ·Thrombosis Research ·(unknown), Doyeun Oh, Chanchai Sittipunt, (unknown), (unknown), Sanjay Aggarwal	20
15	Estimation of resource utilisation difference between lithium and valproate treatment groups from the VALID study 2011 ·Journal of Medical Economics ·(unknown), Sanjay Aggarwal	3
16	Targeting aberrant PI3K pathway signaling with XL147, a potent, selective and orally bioavailable PI3K inhibitor 2007 ·Molecular Cancer Therapeutics ·Geoffrey I. Shapiro, Gerald M. Edelman, Emiliano Calvo, Sanjay Aggarwal, Alexander Laird	14
17	Biomarker development for XL765, a potent and selective oral dual inhibitor of PI3K and mTOR currently being administered to patients in a Phase I clinical trial 2007 ·Molecular Cancer Therapeutics ·Amita Patnaik, Patricia LoRusso, Josep Tabernero, Alexander Laird, Sanjay Aggarwal, Kyriakos P. Papadopoulos	8
18	Present status of TGS-based pyroelectric infrared detectors and computational simulation of their integration with silicon technology 2003 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Ashok K. Batra, J. R. Currie, Sanjay Aggarwal, M. D. Aggarwal, Ratan Lal	2
19	Affect Regulation and Addictive Aspects of Repetitive Self-Injury in Hospitalized Adolescents 2002 ·Journal of the American Academy of Child & Adolescent Psychiatry ·Mary K. Nixon, Paula Cloutier, Sanjay Aggarwal	320
20	Contribution of the S4 Segment to Gating Charge in the Shaker K+ Channel breakdown → 1996 ·Neuron ·Sanjay Aggarwal, Roderick MacKinnon	585

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact